Institutional Sign In

Go

Fresenius Medical Care

Fresenius Medical Care's Cash & Cash Equivalents rose 119% yoy to EUR 2,146 mil in 2018

By Helgi Library - April 2, 2020

Fresenius Medical Care's total assets reached EUR 26,242 mil at the end of 2018, up 9.23% compared to the previous year. ...

Profit Statement
Balance Sheet
Ratios
Valuation

Get all company financials in excel:

Download Sample   $19.99

Get all company financials in excel:

Download Sample   $19.99

Finance

Fresenius Medical Care has been growing its sales by a year on average in the last 5 years. EBITDA has grown by 0% during that time to total of in 2018, or of sales. That’s compared to % average margin seen in last five years.

The company netted in 2018 implying ROE of and ROCE of . Again, the average figures were % and %, respectively when looking at the previous 5 years.

Fresenius Medical Care’s net debt amounted to at the end of 2018, or of equity. When compared to EBITDA, net debt was x, up when compared to average of x seen in the last 5 years.

Valuation

Fresenius Medical Care stock traded at per share at the end of 2018 resulting in a market capitalization of . Over the previous five years, stock price grew by 0% or % a year on average. The closing price put stock at a 12-month trailing EV/EBITDA of x and price to earnings (PE) of x as of 2018.

More Companies in German Pharmaceutical Sector